new_0222_0626|SPRB|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0626|SPRB|1|Spruce Biosciences Inc Total Current Assets (Quarterly) (USD)|Spruce Biosciences Inc Cash and Short Term Investments (Quarterly) (USD)|Spruce Biosciences Inc Inventories (Quarterly) (USD)|Spruce Biosciences Inc Net PP&E (Quarterly) (USD)|Spruce Biosciences Inc Goodwill and Intangibles (Quarterly) (USD)|Spruce Biosciences Inc Total Liabilities (Quarterly) (USD)|Spruce Biosciences Inc Total Current Liabilities (Quarterly) (USD)|Spruce Biosciences Inc Total Long Term Liabilities (Quarterly) (USD)|Spruce Biosciences Inc Total Deposits (Quarterly) (USD)|Spruce Biosciences Inc Book Value (Quarterly) (USD)|Spruce Biosciences Inc Retained Earnings (Quarterly) (USD)|Spruce Biosciences Inc Treasury Stock (Quarterly) (USD)|Spruce Biosciences Inc EV to Revenues|Spruce Biosciences Inc EV to Earnings|Spruce Biosciences Inc EV to Free Cash Flow|Spruce Biosciences Inc EV to Assets (Quarterly)|Spruce Biosciences Inc PS Ratio|Spruce Biosciences Inc PE Ratio|Spruce Biosciences Inc Price to Book Value|Spruce Biosciences Inc PEG Ratio|Spruce Biosciences Inc Debt to Equity Ratio|Spruce Biosciences Inc Dividend Yield|Spruce Biosciences Inc Shareholder Yield (TTM)|Spruce Biosciences Inc Percent of Shares Outstanding Short|Spruce Biosciences Inc Total Receivables (Quarterly) (USD)|Spruce Biosciences Inc Total Payables (Quarterly) (USD)|Spruce Biosciences Inc Total Capital Stock (Quarterly) (USD)|Spruce Biosciences Inc Return on Invested Capital|Spruce Biosciences Inc Quality Ratio Score|Spruce Biosciences Inc Momentum Score|Spruce Biosciences Inc Beta (1Y)|Spruce Biosciences Inc Sustainable Growth Rate (TTM)|Spruce Biosciences Inc Institutional Investor Ownership Percentage|Spruce Biosciences Inc Average Diluted Shares Outstanding (Quarterly)|Spruce Biosciences Inc Total Employees (Annual)|Spruce Biosciences Inc EPS Diluted (Quarterly) (USD)|Spruce Biosciences Inc SG&A Expense (Quarterly) (USD)|Spruce Biosciences Inc Shares Outstanding|Spruce Biosciences Inc Repurchase of Capital Stock (Quarterly) (USD)|Spruce Biosciences Inc Ordinary Shares Number (Quarterly)|Spruce Biosciences Inc Payout Ratio|Spruce Biosciences Inc Quick Ratio (Quarterly)|Spruce Biosciences Inc Normalized Diluted EPS (Quarterly) (USD)|Spruce Biosciences Inc Stock Buybacks (Quarterly) (USD)|Spruce Biosciences Inc Effective Tax Rate (TTM)|Spruce Biosciences Inc Return on Equity|Spruce Biosciences Inc Net Income (TTM) (USD)|Spruce Biosciences Inc Revenue (TTM) (USD)|Spruce Biosciences Inc Dividend Per Share (Quarterly) (USD)|Spruce Biosciences Inc Revenue (Quarterly) (USD)|Spruce Biosciences Inc Gross Profit (Quarterly) (USD)|Spruce Biosciences Inc Pre-Tax Income (Quarterly) (USD)|Spruce Biosciences Inc Net Income (Quarterly) (USD)|Spruce Biosciences Inc Net Interest Income (Quarterly) (USD)|Spruce Biosciences Inc Price (USD)|Spruce Biosciences Inc Total Return Price (USD)|Spruce Biosciences Inc Enterprise Value (USD)|Spruce Biosciences Inc 30-Day Average Daily Volume|Spruce Biosciences Inc 1 Year Price Returns (Daily)|Spruce Biosciences Inc Short Interest|Spruce Biosciences Inc PE Ratio (Forward)|Spruce Biosciences Inc PE Ratio (Forward 1y)|Spruce Biosciences Inc PS Ratio (Forward)|Spruce Biosciences Inc PS Ratio (Forward 1y)|Spruce Biosciences Inc Quarterly EPS Estimates (USD)|Spruce Biosciences Inc Quarterly Revenue Estimates (USD)|Spruce Biosciences Inc Quarterly EPS Surprise|Spruce Biosciences Inc Quarterly Revenue Surprise|Spruce Biosciences Inc Quarterly Actual EPS (USD)|Spruce Biosciences Inc Quarterly Actual Revenue (USD)|Spruce Biosciences Inc Revenue Estimates for Current Fiscal Year (USD)|Spruce Biosciences Inc Revenue Estimates for Next Fiscal Year (USD)|Spruce Biosciences Inc Price Target (USD)|Spruce Biosciences Inc Consensus Recommendation|Spruce Biosciences Inc Price Target Num Estimates|Spruce Biosciences Inc EPS Estimates for Current Fiscal Year (USD)|Spruce Biosciences Inc EPS Estimates for Next Fiscal Year (USD)|Spruce Biosciences Inc Research and Development Expense (Quarterly) (USD)|Spruce Biosciences Inc Reconciled Depreciation (Quarterly) (USD)|Spruce Biosciences Inc Non-Operating Interest Expense (Quarterly) (USD)|Spruce Biosciences Inc Land and Improvements (Quarterly) (USD)|Spruce Biosciences Inc Buildings and Improvements (Quarterly) (USD)|Spruce Biosciences Inc Other Properties (Quarterly) (USD)|Spruce Biosciences Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0626|SPRB|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0626|SPRB|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0626|SPRB|5|106.5|106.5||106.5||106.5|106.5|106.5||106.5|106.5||||1.44755244755||||1.44755244755|||1.44897959184||15.2580645161||106.5|106.5|||31|30.6666666667||30.5|91.375|91.4|91.375|91.375|35||106.5|||91.375||||91.4|||||91.375|91.375|91.375|1.44897959184|1.44897959184|1.44897959184|1.45222929936|1.42857142857|15.2580645161|||||91.3333333333|91.3333333333|91.25||91.25|91.25|24.8421052632|27.7647058824|21.4545454545|13.8823529412|21.4545454545|22.4761904762|26.2222222222|91.375|91.375|91.375|||91.25|||
new_0222_0626|SPRB|6|6|6||6||6|6|6||6|6||||286||||286|||343||31||6|6|||2|3||14|8|5|8|8|12||6|||8||||5|||||8|8|8|343|343|343|314|91|31|||||9|9|4||4|4|19|17|22|34|22|21|18|8|8|8|||4|||
new_0222_0626|SPRB|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0626|SPRB|201909||||||||||||||||||||||||||||||||||9.1437||-0.279|0.457||||||-0.279|||||||||-2.551|-2.551|-0.005||||||||||||||||||||||||2.107|0.002|0.005||||||
new_0222_0626|SPRB|201912|4.652|3.924||||35.329|4.303|31.026||-30.637|-31.302|||||||||||||||1.878|0.001|||||||9.1437||-0.348|0.286|||22.2636|||-0.348|||||||||-3.182|-3.182|-0.06||||||||||||||||||||||||2.848|0.009|0.06||||||
new_0222_0626|SPRB|202003||||||||||||||||||||||||||||||||||9.1437||-0.5652|0.523||||||-0.5652|||||||||-5.168|-5.168|-0.074||||||||||||||||||||||||4.61|0.001|0.074||||||
new_0222_0626|SPRB|202006|38.478|36.601||||9.622|6.335|3.287||29.346|-42.916|||||||||||||||2.656|0.001|||||||21.2636|15|-0.3031|0.727|||22.2636|||-0.3031||||-17.347|||||-6.446|-6.446|-0.092||||||||||||||||||||||||5.662|0.017|0.092||||||
new_0222_0626|SPRB|202009|73.6|72.158||1.869||129.926|10.086|119.84||-51.441|-52.503|||||||||||||1.1752||4.002|0.001||||||50.0219|22.2636|15|-0.4509|1.79|21.2636||22.2636|||-0.4509||||-24.383|||||-9.587|-9.587|-0.079|21.89|21.89|440.4655|92180.1333||272810|||||-11.65||-6.0086||-12.35||||33.75|1.5|4|-3.69|-2.435|7.769|0.008|0.079|||1.869||28.65|
new_0222_0626|SPRB|202012|160.397|157.15||1.793||13.456|9.763|3.693||149.427|-60.841||||-15||||3.7842|||||1.864||3.628|0.002|||||||23.2604|17|-0.39|2.521|23.2604||23.2604|||-0.39||||-29.539|||||-8.338|-8.338|-0.078|24.31|24.31|412.7863|102835.9667||433574|||||-0.59||33.8983||-0.39|||-1.25|33.75|1.5|4|-3.69|-2.435|5.814|0.01|0.078|||1.793||20.73|20.9
new_0222_0626|SPRB|202103|151.586|148.627||1.716||13.268|6.851|6.417||140.723|-70.728||||-7.983||||2.7487|||||1.8358||2.566|0.002|||||||23.2837|19|-0.42|3.103|23.3019||23.3019|||-0.42||||-34.258|||||-9.887|-9.887|-0.089|16.6|16.6|243.0275|54843.6||427766|||||-0.415||-1.2048||-0.42|||-1.25|33.25|1.5|4|-2.1967|-2.27|6.714|0.013|0.089|||1.716||16.2|14.13
new_0222_0626|SPRB|202106|111.369|109.223||1.638||13.342|6.98|6.362||130.106|-82.502||||-4.4481||||2.0136|||||2.1825||1.113|0.003|||||||23.3298|21|-0.5|2.595|23.3701||23.3701|||-0.5||||-39.586|||||-11.774|-11.774|-0.08|11.21|11.21|157.6108|80316.8667||510049|||||-0.4467||-11.9395||-0.5|||-1|32.4|1.6|5|-2.165|-2.355|9.119|0.017|0.08|||1.638||9.21|7.67
new_0222_0626|SPRB|202109|93.922|92.32||1.559||15.367|9.061|6.306||119.72|-93.949||||-1.4966||||1.1737|||||2.0731||2.128|0.003|||1|2.4106|||23.3671|19|-0.49|2.793|23.3799||23.3799|||-0.49||||-41.446|||||-11.447|-11.447|-0.088|6.01|6.01|53.0602|39555.7667|-78.3439|484689|||||-0.5733||14.5344||-0.49|||-1|32.2|1.6|5|-2.255|-2.49|8.607|0.018|0.088|||1.559||4.76|2.58
new_0222_0626|SPRB|202112|||||||||||||||-0.4849||||0.8741|||||5.1782||||||1|3.0244||94.0804||||||||||||||||||||||4.46|4.46|17.1924|7558958.3667|-81.6536|1214959|||||-0.55||||||||11|2|6|-1.9717|-2.3367||||||||2.54|2.13
new_0222_0626|SPRB|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.64|||||||||||||||||||||
new_0222_0626|SPRB|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.705|||||||||||||||||||||
new_0222_0626|SPRB|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.76|||||||||||||||||||||
new_0222_0626|SPRB|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.825|||||||||||||||||||||